Private ovarian cancer screening

We offer two different types of blood tests to detect ovarian cancer to detect suspected ovarian cancer.

From £110

Home » Scanning & Diagnostic Imaging » Private Ovarian Cancer Screening

Private Ovarian Cancer Screening

Ovarian cancer is the fifth most common cause of cancer-related death among UK women and causes 5% of all cancer deaths in women worldwide.

Ovarian cancer can be difficult to diagnose as the symptoms are often similar to other health conditions and include a loss of appetite, frequent urination and bloating, amongst other symptoms. This is one reason why ovarian cancer is often diagnosed at an advanced stage, meaning that a poor survival rate is likely. However, by detecting suspected ovarian cancer early, women are far more likely to survive the illness.

Pall Mall Medical offer two different types of blood tests to help diagnose ovarian cancer:

no-waiting-icon

No Waiting
Times

quick-results-icon

Quick
Results

world-class-icon

World Class
Facilities

prices-icon

Price from
£110

  • Detection of the CA 125 protein in your blood may indicate the presence of ovarian cancer
  • Early detection can increase the rates of survival as only a third of the 6,800 women diagnosed survive for five years. Early detection can increase the survival rate to 90% of women
  • While symptoms don't automatically mean you have ovarian cancer, it is advisable to be aware of them and be tested if they don't seem to subside.

Why Choose us?

  • Detect cancer early
  • Increase your chances of survival
  • Give yourself reassurance
  • No referral needed
  • At your convenience
  • Available at multiple locations

Our Pricing

Service Price
CA125 Blood Test

(excludes appointment, from £25)

£110
HE4 Blood Test

(excludes appointment, from £25)

£121
Combined CA125 & HE4 Blood Test

(excludes appointment, from £25)

£185

Ovarian Cancer Health Screen

(includes Gynaecology Consultation, combined CA125 & HE4 Blood test, Ovarian Ultrasound Scan

£535

More about ovarian cancer screening

Paper summary: from the Departments of Obstetrics and Gynecology, and Radioisotope Laboratory at Xuzhou Central Hospital

To assess the ability of human epididymis protein 4 (HE4) and CA-125 to distinguish among benign, borderline, and malignant pelvic masses in premenopausal women.

Make your next step...

Use your medical insurance at Pall Mall Medical...